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1. Introduction 
Ectopic pregnancy represents a rare pregnancy complication. In the last 20 years, with the 
use of IVF, heterotopic pregnancies have become more frequent, while this percentage 
differs between IVF programs. Many factors contribute to this, like the active 
management of hydrosalpinx or treatment of Chlamydia infection before starting a cycle. 
Although, in vitro fertilization is an expensive treatment, ectopic complication adds to this 
cost.  
Not a lot of studies exist for ectopic pregnancy after IVF. Most of them are case reports.  Not 
a standard way exists, for dealing with heterotopic pregnancies, even in the era of modern 
laparoscopy. Not a lot of research has been performed on molecules that involved. Studies 
have tried to associate certain techniques during IVF, with this entity, but with controversial 
results. There is no standard form for diagnosing, dealing and presenting heterotopic 
pregnancies. Most of them are diagnosed when ruptured. Because it is rare event, cost-
effectiveness studies could not be performed and this complication is added to the overall 
IVF. Knowledge, on this field, is taken from the management of ectopic pregnancies in the 
general population, even if these present at a lower percentage.  
The purpose of the study is to systematically evaluate studies on molecular aspects of 
ectopic pregnancy, the ART techniques that are associated with ectopic pregnancy, the 
diagnosis of this entity and finally present case reports of heterotopic pregnancies and their 
management. At the end, cost-effectiveness models from the general population will be 
presented in parallel with systematic examination of these studies. Finally, new research 
targets will be pointed.  
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2. Methods 
2.1 Identification and eligibility of relevant studies 
Medline searches (up to March 2011) were performed using various combinations of terms: 
ectopic pregnancy, heterotopic pregnancy, In Vitro Fertilization, Intrauterine Insemination, 
pelvic inflammatory disease, Chlamydia trachomatis, heterotopic pregnancy, cervical 
pregnancy, cost-effectiveness.  
The search was complemented with perusal of the bibliographies of retrieved papers and 
review articles. We included studies that evaluated the presence of an ectopic pregnancy 
after IVF in case reports, although in other chapters information was obtained from studies 
in the general population.  
Number of tested samples was not an exclusion criterion. Only studies including human 
subjects were included.  
2.2 Data extraction 
For each study, information was obtained on authors, journal, year of publication, country 
and years of study enrollment, study design and study target, number of tested samples, 
tissue and disease tested, searched molecules and pathways involved, clinical outcome and 
whether biopsy was performed with the site.  
Data extraction was performed independently by two investigators, and conflicts were 
resolved after discussion.  
3. Main outcomes 
3.1 Statistical methods 
Frequencies of all important parameters were performed. Statistical analyses were 
performed in using the Statistical Package for Social Sciences (SPSS) version 12.0 (SPSS, 
Chicago, IL, USA).  
3.2 Founding source 
No sponsor was involved in the study design, report writing, or paper submission.  
4. Results 
4.1 Studies examining biological factors playing a role to ectopic pregnancy 
A total of 42 abstracts were retrieved and further screened. Only studies that performed 
basic investigations were included in this part. Out of 20 included studies, 3 were performed 
in USA (15%), 2 in Germany (10%), Israel, Sweden and UK, and from one (5%) in Brazil, 
Canada, China, Croatia, Denmark, Finland, Hungary, India and Poland. 8 (40%) of them 
considered themselves clinical, 8 (40%) experimental, 1 (5%) prospective, 1 (5%) as pilot 
study, 1 (1%) as preliminary report, 1 (5%) as hypothesis testing. The type of study per 
country initiated can be seen in Fig 1.  
All studies selected used human tissue. Five studies used fallopian tubes (25%). From the 
other studies 1 (5%) used fallopian tube and peripheral blood, 1 used deciduas, placenta, 
primary first trimester trophoblast cells and peripheral blood, 1 used decidual tissue, 2 
endometrial tissue, 1 epithelial tissue and 1 mucosal tissue, 1 cervical specimen and  
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Fig. 2. Type of study per tissue used when examining biological factors in ectopic pregnancy 
fallopian tube samples, 1 used human endometrium and fallopian tube, 2 used human 
placental tissue, 1 used ovarian, prostate, endometrial, tubal and semen, 1 used trophoblast, 
2 used serum samples, 1 used transervical specimens and one used stimulated cervical 
mononuclear cell supernatants. The type of study per tissue used can be seen in Fig 2.  
4 (20%) of the studies were published in American Journal of Reproductive Immunology, 2 
(10%) in Human Reproduction and from 1 (5%) in Molecular Human Reproduction, 
Reproduction, Reproductive Biology & Endocrinology, Reproductive Sciences, Biology of 
Reproduction, Cellular Microbiology, Clinical and Vaccine Immunology, European Journal 
of Obstetrics & Gynecology, Histochemistry & Cellular Biology, Infection and Immunity, 
The Journal of Immunology, The Journal of Infectious Diseases ,The Journal of Clinical 
Endocrinology & Metabolism, The Medical Hypothesis journal. The distribution of type of 
study per Journal is seen in Fig 3. Eight studies (40%) did not mentioned their controls, four 
studies (20%) used normal pregnant patients and intrauterine pregnancy, and from one 
study (5%) used women with no infection and without infertility problem, normal desidual 
tissue, normal endometrium and normal Fallopian tube, normal pregnant patient peripheral 
blood, spontaneous abortion,, tissue from women undergoing tubal ligation with segmental 
resection and women with viable and non-viable intrauterine pregnancy.  
Samples size examined ranged from 3 (in each group) to 144. Disease distribution examined 
presented as: ectopic pregnancy (8/40%), spontaneous abortion and ectopic pregnancy 
(2/10%), Chlamydia infection (2/10%), Chlamydia infection in patients with no infertility 
compared with women with Chlamydia and tubal damage, ectopic pregnancy and 
decidualized endometrium, ectopic pregnancy and blighted ovum, ectopic pregnancy and 
Chlamydia infection, pelvic inflammatory disease and ectopic pregnancy, post IVF ectopic 
pregnancy, viable ectopic pregnancy while 1 (5%) did not mentioned disease. Funding 
source of each study per Journal published is seen on Fig 4.  
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Fig. 3. The distribution of type of study per Journal when examining biological factors in 
ectopic pregnancy 
 
Fig. 4. Funding source of each study per Journal published 
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4.2 Outcomes 
All studies except two (3/15%) mentioned the molecule studied. Two studies (10%) 
mentioned C Trachomatis DNA, one C Trachomatis serum antibodies, while from one study 
mentioned CD14B7H4,CHSP-60,E-Cadherin,estrogen receptor, IgG antibodies, IL-1, IL-8, Ki-
67, MMP-2, PIGF, SLIT/ROBO proteins, Svcam-1, TAG-72, Treg. Ten studies (50%) did not 
mentioned a second molecule while the other studies mentioned CT antibodies (1/5%) 
chlamydial sarkosyl-soluble 57-kDa protein, cHSP 60, Cytokeratin 7, estrogen receptor, 
hCG, IL-1a, MMP-9, P38 and progesterone. 11 studies (55%) did not mentioned third 
outcome while the other ones mentioned Chsp 60 (2/10%), bhCG, cHSP 10 (1/5%), ERK, 
Fibronectin, FOXP 3, IL-10 and MMP-14. Thirteen studies (13/65%) did not mentioned a 
fourth outcome, while the other mentioned activin (1/5%) IFN-Ǆ, Laminin, MAPK, 
neurophilin, p38 inhibitor and TIMP-1. Fifth molecule was mentioned in only 6 studies. 
Only four studies mentioned pathways involved: invasive pathway, p38 MAP-kinasses 
pathway, ERK-MAPK pathway and SLIT/ROBO pathway. Only two studies (2/5%) 
mentioned intervention medication.  
In terms of bio-analytic techniques, PCR techniques and immunohistochemistry was mainly 
used. For immunohistochemistry techniques, four studies (20%) did not mentioned it, seven 
studies (7%) mentioned as immunohistochemistry, 23 (15%) as immunofluorence 
immunohistochemistry, and from one as electron microscopic immunohistochemistry, 
immunoblotting, immunoperoxidase staining (IP), immunosorbent assay, microimmuno-
fluoresence, microimmunofluorence-immunoblot. For PCR techniques, eleven studies (55%) 
did not mentioned PCR technique, 4 (20%) studies mention it as quantitative PCR, 2 (10%) 
studies mention it as PCR, two (10%) as RT-PCR, and 1 (5%) as N-PCR.  
When ectopic pregnancy exists, Arias-Stella reaction is observed in endometrium. At that 
time, B7H4 positive macrophages is significantly lower when compared with secretory 
endometrium (Wicherek et al., 2009) 
Chlamydia trachomatis are highly associated with ectopic pregnancy (Brunham et al., 1992). 
Chlamydia trachomatis antigens, exist in asymptomatic, culture negative men and women 
with chronic infection and may act as immunostimulants and re-activate Chlamydia (Toth et 
al., 2000). After first episode of ectopic pregnancy, antibody response to conserved epitope 
of cHSP-60 (Chlamydia heat shock protein) is associated with increased probability of 
adverse pregnancy outcome (Sziller et al., 2007). So this biomarker could be used for 
counseling women with first episode of ectopic pregnancy: if sensitized to this epitope, in 
vitro fertilization should be offered. Another indication for the significance of this biomarker 
is that in infertile women, when Chlamydia infected tissue is exposed to Chlamydia heat 
shock proteins (cHSP-60 and cHSP-10) increased release of IFN-gamma, IL-10 and TNF-
alpha (Srivastava et al., 2008) affect mucosal immune function. From the other side, Ct-IgG 
and c-hsp6 antigens, were not found as an independent predictor of ectopic pregnancy 
(Bjartling et al., 2006).  
In the fallopian tube of serologically positive patients for Chlamydia trachomatis that had 
ectopic pregnancy, there is an increase in the expression of activin ǃΑ subunit, type II 
receptors, follistatin and iNOS (Refaat et al., 2009).  
In infected tubes from Chlamydia trachomatis infection, interleukin -1 production from 
epithelial cells initiates tissue destruction. By blocking IL-1 with IL-1RA receptor antagonist 
and/or IL-10, tissue destruction is eliminated. Chlamydia infected cells, also, produce IL-8 
by ERK MAPK pathway (Buchholz et al., 2007).  
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Regulators T cells (Treg) express LH/CG receptor on their surface during pregnancy and 
are present at the fetal-maternal interface, attracted by high levels of human chorionic 
gonadotrophin. In ectopic pregnancies, regulatory T cells are not attracted to the same 
degree by the lower levels of hCG (Schumacher et al., 2009).  
Another possible biomarker for ectopic pregnancy after IVF is E-cadherin, because it is 
highly expressed in cytotrophoblast cells of chorionic villi from these pregnancies, when 
compared with spontaneous ectopic pregnancy (Revel et al., 2008).  
From micro-array studies, Savaris et al, by using the model of ectopic pregnancy, found that 
the transcriptome of the decidua is influenced by trophoblast products, in endocrine fashion 
(Savaris et al., 2008).  
In close proximity of the tubal implantation site, MUC-1 and TAG-72 are present in the 
epithelial cells and might contribute to the deeper trophoblast invasion in the tubal wall 
(von Rango et al., 2003) while a significant reduction in NK-cell numbers at the tubal 
implantation site, could be seen, induced by local antigen-presenting cells in the presence of 
mucins (Laskarin et al., 2010).  
Viable tubal pregnancies implant at the mesosalpingeal side of the tubal wall show a 
massively increased invasion of extravillous trophoblast cells (EVT) into the tubal wall, and 
the proliferation of trophoblast cells extends deeply into the invasive zone in the invasive 
pathway (Kemp et al., 1999). Tubal pregnancies that will undergo tubal abortion implant at 
the antimesometrial side which show shallow invasion and poor trophoblast proliferation 
(Kemp et al., 1999). In extrauterine pregnancy, expression of integrin subunit ǂ3 is nearly 
exclusively restricted to the basal plasmalemma of the first layer of trophoblast cells while 
only the first proximal layer of EVT (in direct contact to the basement membrane) expresses 
integrin ǂ6. The switch to the integrin subunits ǂv and ǂ5 takes place already in the second 
layer of trophoblast cells, as soon as the latter detach from the basement membrane (Kemp 
et al., 2002).  
In tubal pregnancies, MMP-9 and TIMP-1, -2 and -3 are produced by all types of extravillous 
cytotrophoblast (EVCT) cells, while MMP-2 and -14 mainly exist in distal column 
cytotrophoblast (CCT) cells and invasive EVCT cells (Bai et al., 2005). In parallel, MMP-14 
and TIMP-1 and -2 are increased along the invasive pathway toward maternal interstitium. 
MMP-2, -9 and -14 and TIMP-1, -2 and -3 were all detected in the villous CT (VCT) cells (Bai 
et al., 2005).  
Another promising technique for early detection of an ectopic pregnancy is that trophoblast 
cells can be reliably obtained and identified among cervical cells in the first trimester and 
labeled with antibody to HLA-G. The number of trophoblast cells per total cervical cells 
(trophoblast frequency) is significant lower in ectopic pregnancy when compared to 
intrauterine pregnancy but not to blighted ovum (Imudia et al., 2009). Using ROC curves the 
positive predictive value for abnormal pregnancy was 97% and the negative predictive 
value was 87%. From intrauterine tissue and sera, Horne et al, examined PIGF, localized to 
the cytotrophoblast cells (Horne et al, 2010). Expression of PIGF mRNA was significantly 
reduced in trophoblast cells, isolated from women with ectopic pregnancy compared with 
intrauterine pregnancies. Serum PIGF was undetectable in women with tubal ectopic 
pregnancies and reduced, or undetectable, in miscarriage compared with viable intrauterine 
pregnancies.  
From the other side, it seems that SLT/ROBO pathway and protein expression in 
endometrium and fallopian tube, is not implicated in ectopic pregnancy because known 
factors that contribute to EP (e.g. smoking/cotinine or chlamydial infection) do not alter 
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protein expression (Duncan et al., 2010). Also serum VCAM-1 was found comparable 
between the three pregnancy types, normal, ectopic and failed thus making this marker not 
useful for the diagnosis of ectopic pregnancy (Daniel et al., 2000).  
Also a role for ectopic pregnancy formation might exist from ovulation induction regimens. 
Clomiphene citrate, which used for anovulatory infertility, may indirectly contribute to 
ectopic pregnancy creation. Chronic treatment with clomiphene activates estrogen receptors, 
particularly in cilia, and inducing tubal apoptosis of isthmus epithelial cells while slowing 
oocyte cumulus complex passage from the fallopian tube (Shao et al., 2009). This may 
contribute to ectopic pregnancy formation.  
5. Section 2 
5.1 Ectopic pregnancy and IVF 
A total of 56 abstracts were retrieved and further screened. Out of 40 included studies, 10 
(25%) were performed in USA, 3 (7.5%) in England, India and in Netherlands, 2 (5%) in France, 
Greece, Israel, Italy and Nepal, while 1 (2.5%) in Australia, Canada, Germany, Japan, Jordan, 
Korea, Norway, Singapore, Taiwan, Thailand and between USA/Sweden. 17 (42.5%) of them 
considered themselves retrospective, 11 (27.5%) as case report, and from 1 (2.56%) as cohort 
study, prospective randomized double blinded cross over study, prospective cohort study, 
population based cost-effectiveness study, epidemiological study, economical analysis, cost 
effectiveness analysis, cost benefit analysis, cost analysis, while 3 (7.5%) do not mentioned the 
type of study. The type of study per country initiated can be seen in Fig 5.  
 
 
Fig. 5. The type of study per country initiated examining IVF and ectopic pregnancy 
All studies selected used human tissue. Fourteen studies mentioned embryo (35%) as tissue 
examined plus 4 (10%) mentioned especially the blastocyst, 4(10%) used fallopian tube and 
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from 1 (2.5%) used embryos with thickened zona pellucida, fallopian tube ectopic 
pregnancy and sperm with abnormal characteristics, hydrosalpinx, ovarian tissue and 
trophoblastic tissue, while one tested newborns for congenital abnormalities after failed 
emergency contraception while 12 (30%) did not specified the tissue examined. The type of 
study per tissue used can be seen in Fig 6.  
 
 
Fig. 6. The type of study per tissue used examining IVF and ectopic pregnancy 
12 (30.0%) of the studies were published in Fertility & Sterility,5 (12.5%) in Human 
Reproduction, 5 (12.5%) in the Journal of Assisted Reproduction & Genetics, and from 1 
(2.5%) in Acta Obstetricia et Gynecologica Scandinavica, American Journal of Emergency 
Medicine, Annals Academy of Medicine, BMC Pregnancy & Childbirth, BMJ, British Journal 
of General Practice, British Journal of Obstetrics & Gynecology, Clinical Chemistry, 
Contraception, European Journal of Obstetrics, Gynecology & Reproductive Biology, 
International Federation of Gynecology & Obstetrics, International Journal of Gynecology & 
Obstetrics and Journal of Obstetrics & Gynecology, Kathamandu University Medical 
Journal, Nepal Medical College Journal, Obstetrics & Gynecology, Sex Transmission 
Infections and The Lancet. The distribution of type of study per Journal is seen in Fig 7. 
Samples size examined ranged from 1 (case reports) to 44. Disease distribution examined 
presented as: ectopic pregnancy (17/42.5%), and from 1 (2.5%) bilateral tubal ligation, 
chlamydial infection-tubal infertility-ectopic pregnancy ,ectopic pregnancy on patients after 
IVF with abnormal sperm characteristics, ectopic pregnancy after oocyte donation in 
menopausal patients, ectopic pregnancy after donation surviving even with the absence of 
exogenous steroids, ectopic pregnancy after embryos with thickened zona pellucida, ectopic 
pregnancy after empty follicle syndrome, ectopic pregnancy after exposure to 
levonorgestrel, heterotopic abdominal pregnancy, heterotopic abdominal pregnancy, ectopic 
pregnancy after hydrosalpinx, menopause and oocyte donation, ovarian heterotopic 
pregnancy, ectopic pregnancy after pelvic inflammatory disease, pelvic inflammatory 
disease-ectopic pregnancy and neonatal complications, primary infertility, tubal factor 
infertility and bilateral ovarian pregnancy, tubal sterilization while 3 (7.5%) did not 
mentioned disease. Funding source of each study per Journal published is seen on Fig 8.  
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Fig. 7. The distribution of type of study per Journal examining IVF and ectopic pregnancy 
 
 
Fig. 8. Funding source of each study per Journal published examining IVF and ectopic 
pregnancy 
5.2 Outcomes 
5.2.1 Factors contributing to ectopic pregnancy after IVF 
Pyrgiotis et al, retrospectively analyzed a large series of fresh (n=2812) and frozen embryo 
transfers (n=405) showing a 2.4% and 7.6% EP rate, respectively (Pyrgiotis et al., 1994). 
Tubal factor presented as 85.7% of all causes of ectopic pregnancies. In a previous study, an 
EP rate of 3.3% was found (26 patients) and the major contributing factor was a prior ectopic 
(Karande et al., 1991). Heterotopic pregnancy rates remained low in both studies while the 
majority of them were tubal. Also cervical pregnancies were low.  
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Clayton et al, in the largest series of 94.118 pregnancies found an EP rate of 2.2% in fresh 
non-donor cycles while ZIFT procedures EP rate was 3.6% (Clayton et al., 2006). Tubal factor 
with or without hydrosalpinx was the main factor of ectopic pregnancy while 
endometriosis, uterine factor and diminished ovarian reserve was some of the less but 
important factors. Although all other factors may be well understood, the last factor could 
be explained from the fact that when higher implantation embryo potential was present, EP 
rate was minimal. When two or less embryos transferred, then the EP rate was less than 
when three or more embryos transferred.  
To the extent of the previous study, abnormal embryogenesis was a major factor for ectopic 
pregnancy. From this study it was found that DNA aneuploidy was associated with tubal 
implantation in 33% (Karikoski et al., 1993). Similar rates (24%) of abnormal amount of DNA 
content in tubal pregnancies was found also by Toikkanen et al., 1993.  
In a recent study Chang et al, found that tubal factor infertility and endometriosis was the 
main factor (Chang et al., 2010). Tubal surgery and previous ectopic pregnancies was 
another important factor while risk for EP was seriously decreased with a previous live 
birth. Donor oocytes do not attribute to more ectopic pregnancies and this apply to higher 
embryo implantation potential, as mentioned above.  
Contradictory to previous results, Bhattacharya et al, found that ectopic pregnancies in IVF 
are associated with significantly lower percentage of motile sperm (Bhattacharya et al., 
2010).  
A more detailed approach follows: 
5.2.2 Heterotopic pregnancy 
It is considered a rare entity of ectopic pregnancy (1/30000) and could be seen especially 
after IVF(<0. 01) (Dimitry et al, 1990; Molloy et al., 1990). It has been presented in literature 
in various forms: 1) Triplet heterotopic pregnancy a) in a previous caesarian scar and 
intrauterine pregnancy b) a tubal singleton and two intrauterine pregnancies and an  
ovarian abscess c) bilateral tubal and intrauterine pregnancy 2) Cornual pregnancy a) 
recurrent cornual pregnancy b) cornual pregnancy and twin intrauterine pregnancy 3) 
heterotopic pregnancy with intrauterine dizygotic twins after blastocyst transfer 4) 
heterotopic cervical pregnancy a) intrauterine and twin cervical pregnancy b) cervico-istmic 
pregnancy 5) Heterotopic pregnancy in parallel with ovarian hyperstimulation syndrome 6) 
heterotopic pregnancy ruptured after spontaneous abortion.  
Eventually the presence of an intrauterine gestation sac in a patient without symptoms 
should not exclude the diagnosis of a concomitant extrauterine pregnancy until the pelvis is 
carefully visualized (Rizk et al., 1991).  
5.2.3 Differences in the prevalence in different countries of the world 
EP complicates about 2% of all pregnancies. Although no studies exists that specifically 
describe the prevalence in different countries, especially after IVF treatment, certain studies 
present this, as a secondary outcome. In Nigeria (Okohue et al., 2010), prevalence for EP was 
7.8% after IVF, while in general population in the same country, EP rate was 1.74% (Musa et 
al., 2009). The same percentage in Jordan was 0.005% (Obeidat et al., 2010). In Cameroon, 
this percentage is 0.72% (Leke et al., 2004). In a large follow up study, in Sweden, ectopic 
pregnancy rates where compared between women from different countries of birth, but 
small differences were found (Eggert et al., 2008). In New York, ectopic pregnancy rates in 
black women are 4.78% (Fang et al., 2000).  
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5.2.4 Contraception as a risk factor 
Ghosh et al, described a right ampullary ruptured ectopic pregnancy after the failure of 
levonorgestrel as emergency contraception (Ghosh et al., 2009), while Fabunmi and Perks, 
reported a case of Caesarean section scar pregnancy after the same LNG failure (Fabunmi & 
Perks, 2002). From the other side, opposite to the numerous case reports, De Santis et al, in a 
retrospective observational cohort study found no association of LNG failure with ectopic 
pregnancy (De Santis et al., 2005).  
5.2.5 Ectopic pregnancy rates in fresh vs. frozen cycles 
Controversy exists in this issue. Jun et al, found no difference in ectopic pregnancy rates 
between fresh and frozen cycles while Yanaihara et al, found a significant difference in 
ectopic pregnancies when two frozen blastocysts were transferred, than one (Jun et al., 2007; 
Yanaihara et al., 2008). From the other side, Ishihara et al, in a large registry retrospective 
study, found that frozen-thawed single blastocyst transfer significantly reduce EP rates 
(Ishihara et al., 2010). Even when data were stratified for age, EP rates varied, but remained 
low.  
5.2.6 Day 3 versus day 5 
Milki et al, found no difference in ectopic pregnancy rates when blastocyst transfer 
compared with day 3 embryo transfer (Milki et al., 2003). In this study important 
confounding factors like tubal disease between the two groups, cryopreserved transfers but 
not number of embryos transferred were checked between the two groups and no 
significant difference was found.  
5.2.7 Blastocyst (single vs. double blastocyst transfer) 
Knopman et al, reported a heterotopic abdominal pregnancy after the transfer of two 
blastocysts (Knopman et al., 2006). Intrauterine pregnancy miscarried first while abdominal 
pregnancy ruptured two weeks later and ectopic removed by laparoscopy. Ectopic 
pregnancies are significant lower when single frozen-thawed blastocysts transferred 
compared with two blastocysts (Yanaihara et al., 2008).  
5.2.8 Oocyte donation and ectopic pregnancy rates 
Cohen et al, found that hydrosalpinx patients that undergo oocyte donation have higher 
ectopic pregnancy rates than patients in the same program with no hydrosalpinx (Cohen et 
al., 1999). Possible explanation for that is the chronic alteration of endometrium rather the 
direct embryotoxic effect of hydrosalpinx fluid. In case, after oocyte donation, an ectopic 
takes place, minimal monitoring may allow rupture of ectopic with significant complication 
(Ledger et al., 1992). Mantzavinos et al, reported three case of ovarian pregnancy after 
oocyte donation (Mantzavinos et al., 1994). Cases were resolved with laparoscopy and 
removal of ovarian pregnancy tissue. Pantos et al, in a large series of donation patients 
found only one ectopic pregnancy (Pantos et al., 1993). Rosman et al, in a large retrospective 
study (4186 non-donor IVF cycles vs. 884 donor ET cycles found that there is no difference in 
ectopic pregnancy rates between donor and IVF cycles (Rosman et al., 2009). From the other 
side, donor patients showed significant lower incidence of tubal disease than standard IVF 
patients.  
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5.2.9 The ICSI role  
In a large retrospective study, Clayton et al, found that use of ICSI was not associated with 
EP while male factor infertility was associated more with EP with all other races than white-
non-Hispanic (Clayton et al., 2006).  
5.2.10 Ultrasound guided embryo transfer 
In a meta-analysis of clinical trials (on 5,968 ET cycles), comparing ultrasound guided ET vs. 
clinical touch ET (Abou-Setta et al., 2007), it was found that ectopic pregnancy rates were no 
different between the two groups. In a another meta-analysis on 17 studies,(Brown et al., 2010), 
it was found the same results, although it was stated that EP are relatively rare and study 
sample sizes limit the ability to detect such differences. Even when a single clinician performs 
all embryo transfers, (Kosmas et al., 2007), no difference in ectopic pregnancy rates was found.  
5.2.11 Assisted hatching 
Hagemann et al, found no difference in ectopic pregnancy rates in patients that their 
embryos had assisted hatching or not (Hagemann et al., 2008). From the other side Milki et 
al, in a large series of retrospectively examined patients saw that a significant higher ectopic 
pregnancy rate was found in cases where assisted hatching (AH) was performed when 
compared with cases that hatching was not preformed (Milki et al., 2004). Possible 
explanation for that is: 1) assisted hatching may accelerate embryo implantation, 2) a 
mechanism exists, that prevents embryos that reached fallopian tube to divert back to uterus 
and 3) the much higher embryo transfer volume that used in certain IVF programs.  
5.2.12 Air bubble position after embryo transfer 
No difference in ectopic pregnancy rates was observed with different distances of embryo 
deposition from the uterine fundus (10-15 mm or < 10 mm) (Pacchiarotti et al., 2007).  
5.2.13 Reanastomosis 
Patients with tubal infertility may undergo microsurgical reconstructive surgery of the 
fallopian tubes for adhesiolysis, anastomosis, fimbrioplasty, salpingostomy, and refertilization 
after former sterilization. These patients, if choose the microsurgical approach, show higher 
ectopic pregnancy rates after a single IVF trial (Schippert et al., 2009). From the other side, in a 
small series of patients, higher incidence of ectopic pregnancies was observed when previous 
tubal sterilization was reversed by laparoscopy than open microsurgical reversal (Tan et al, 
2010). Even if suture less laparoscopic tubal re-anastomosis was performed (using a 
serosamuscular fixation/biological glue technique) an ectopic pregnancy rate of 3.9% was 
observed (Schepens et al., 2011). In a small series of robotic tubal reanastomosis (Dharia Patel 
et al., 2007) more ectopic pregnancies were observed when compared with open reanastomosis.  
5.2.14 Other complications of ectopic pregnancies 
Rh immunization could be observed in ruptured ectopic pregnancy.  
6. Section 3 
6.1 Diagnosis of an ectopic in IVF  
Pregnancies of unknown location include viable pregnancies, ectopic pregnancies and 
miscarriages (Condous et al., 2005). Only a small portion of them are high risk pregnancies 
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(Condous et al., 2005) and there is difficulty in diagnosis and management. Serial 
measurements of hCG and progesterone should be performed on a wait and see approach, 
in parallel with TVS. Serum hCG increase over 48 h of more than 66% – that is, 
an hCG ratio of >1.66 – correlates well with a developing intrauterine pregnancy. The use of 
discriminatory zone technique (Condous et al., 2005), is currently evaluated for prediction of 
probability of ectopic pregnancy. By this technique, if an intra-uterine sac cannot be seen on 
ultrasound scan above the threshold value, then steps must be taken to determine whether 
the pregnancy is abnormal or ectopic. After that a D&C can be safely performed only when 
a non-viable pregnancy has been documented by either a serum progesterone level of 15.9 
nM or the absence of a rise in serum hCG after 2 days; that is, an hCG ratio of <1.50 
(Pisarska et al., 1998).  
6.2 Transvaginal ultrasound and hCG levels for prediction  
With the use of TVS, before 35 days a pregnancy could be considered as a pregnancy of 
unknown location, from 35 to 41 days a pregnancy of uncertain viability and from 42 days a 
viable intrauterine pregnancy (Bottomley et al., 2009. Time for diagnosis of ectopic 
pregnancy was 48 days. In case, previous ectopic pregnancies took place, then diagnosis 
could be made before this time. Viability scans should be deferred until 49 days of gestation 
with a minimal benefit delaying after that. The addition of abdominal pain and vaginal 
bleeding ads to ectopic pregnancy risk. Statistical models have been developed, based on the 
hCG ratio to predict the outcome of pregnancies of unknown location and especially ectopic 
pregnancies (Kirk et al., 2006), but this is not easily implemented in clinical practice.  
6.3 Newer biomarkers for ectopic pregnancy 
Daniel et al, tested for serum sVCAM-1, ectopic and normal pregnancies, but did not found 
any difference (Daniel et al., 2000).  
C. trachomatis antigen and nucleic acid could be found at 33% among ectopic pregnancies 
tissue even if they are negative for cervical Chlamydia (Toth et al., 2000).  
Activin A subunit, type II receptors, follistatin, and iNOS show increased expression within 
the fallopian tube of ectopic pregnancy patients tested serologically positive for C. 
trachomatis (Refaat et al., 2009). Especially for iNOS, elevated activity positively correlates 
with protection from hydrosalpinx formation and prevention of the systemic spread of C. 
trachomatis. In a clinical setting, Florio et al, found that Activin A levels were significantly 
lower in spontaneous abortions and intrauterine pregnancies than ectopic ones,and at the 
cutoff of 0.37ng/ml a sensitivity and a specificity of 100 and 99.6%, respectively, was 
achieved, for prediction of EP (Florio et al., 2007). From the other side, on a different 
approach, Kirk et al, found no more discriminatory capacity of Activin A and inhibin than 
serum hCG levels for ectopic pregnancy in case of a pregnancy of unknown location (Kirk et 
al., 2009).  
7. Section 4 
7.1 Management of specific ectopic pregnancies 
In this section, a total of 26 abstracts were retrieved and further screened. Only studies that 
performed clinical interventions for ectopic pregnancy after IVF were included in this part. 
Out of 16 included studies, 5 (31.25%) were performed in Taiwan, 4 in USA (25%), 2 in Italy 
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(12.5%), 1 (6.25%) in France, 1 in Germany (6.25%), 1 (6.25%) in Netherlands, 1 in Turkey 
(6.25%), and one in Serbia and Montenegro. 15 (93. 75%) of them considered themselves case 
report while 1 (6. 25%) clinical. The type of study per country initiated can be seen in Fig 9.  
 
 
Fig. 9. The type of study per country initiated 
All studies selected used human tissue. Thirteen studies did not mention anatomical tissue 
used (81.25%). From the other studies 1 (6.25%) used fallopian tissue, 1 used endometrium 
& fallopian tube, and one used cornual pregnancy. The type of study per tissue used can be 
seen in Fig 10.  
 
 
Fig. 10. The type of study per tissue used 
10 (62.5%) of the studies were published in Fertility & Sterility, 2 (12.5%) in Human 
Reproduction and from 1 (6.25%) in Archives Gynecological & Obstetrics, Journal of 
Obstetrics & Gynecology, Journal of Assisted Reproduction & Genetics and Mayo Clinical 
Proceedings. The distribution of type of study per Journal is seen in Fig 11. All studies did 
not mention their controls.  
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Fig. 11. Type of study per Journal published 
Samples size examined ranged from 1 (case report) to 104. Disease distribution examined 
presented as: heterotopic cesarean scar pregnancy, (5/31.25%) (one study described ectopic 
twin pregnancy in a Cesarean section scar (1/6.,67%) and a second described a triplet 
heterotopic cesarean scar pregnancy), heterotopic cervical pregnancy (4/25%), cornual 
pregnancy (1/6.25%), heterotopic cornual pregnancy, heterotopic triplet pregnancy, 
Intersitial Heterotopic pregnancy, unilateral ectopic twin pregnancy while one study did not 
mentioned the type of ectopic pregnancy. Tissue used per disease is seen on Fig12.  
 
 
Fig. 12. The type of tissue used per disease 
Funding source of each study per Journal published is seen on Fig 13.  
 
 
Fig. 13. Funding source of each study per Journal published 
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Five studies (31.25%) did dot used any pharmacological interventions while the other 11 
described it: two studies used potassium chloride, one study used sodium chloride, one 
used systemic methotrexate, one used vasopressin. The other six studies described the 
pharmacological interventions from IVF, previously performed.  
7.2 Rare cases of ectopic pregnancies  
Papers that report ectopic pregnancies after IVF and their clinical picture will be presented 
in this section. Case studies will be presented according to anatomical location and 
management.  
7.2.1 Ovarian ectopic pregnancies  
In a large series of patients, Raziel et al., found that ovarian ectopic pregnancy rate 
comprises 2.7% of all ectopic pregnancies, is highly associated with the use of intrauterine 
device and treated with laparoscopic wedge resection (Raziel et al., 2004). The use of 
ultrasound for diagnosis of hemoperitoneum makes culdocentesis not necessary.  
Case reports presenting ovarian ectopic pregnancies present: 1) ovarian heterotopic 
pregnancy after IVF (Kamath et al., 2010), 2) bilateral ovarian pregnancy after IVF and 
previous tubal pregnancy after reanastomosis (Han et al., 2004), 3) left ovarian pregnancy 
after empty follicle syndrome in IVF treatment (Qublan et al., 2008), 4) ovarian pregnancy 
from cornual fistulae after bilateral salpingectomy and IVF treatment (Hsu et al., 2004).  
7.2.2 Management of a late ectopic pregnancy 
A case of a cervical intrauterine pregnancy has been reported by Fruscalzo et al., after IVF 
(Fruscalzo et al., 2007). At the 13th gestational week, a viable intrauterine pregnancy and a 
non viable cervical pregnancy were diagnosed. The cervical pregnancy was anteriorly 
confined near a thick cervical blood vessel with low resistance flow at Doppler ultrasound. 
Due to the proximity to the cervical venous vessel, there was increased hemorrhagic risks 
associated with a cervical pregnancy expulsion After hospitalization and observation, 
cervical pregnancy was expulsed at 15th gestational week + 6 days and hemorrhage was 
managed through cervical curettage and multiple cervical stitches under general anesthesia. 
Unfortunately, some hours later, intrauterine pregnancy expulsed also, leading to a 
curettage.  
Another case of heterotopic pregnancy at 16 wks gestation after IVF was presented by 
Hassiakos et al., 2002. It was ruptured and presented with intra-abdominal bleeding and 
hemorrhagic shock.  
7.2.3 Maternal-embryo complications from use of Potassium chloride 
A study by Gyamfi et al, described a cervical heterotopic pregnancy (one in the intrauterine 
cavity and the other in the upper portion of the cervix) treated with KCl (3 mL ) injection 
and aspiration of the gestational sac contents (Gyamfi et al., 2004). A blood supply, separate 
from that of the remaining pregnancy was seen at 19 wks by color Doppler. Unfortunately 
remaining trophoblastic tissue did not resolve, leading to obstetric hemorrhage at 31 wks 
gestation and subsequently to emergency cesarean hysterectomy with a viable infant,while 
patient waited for an elective Cs at 32 wks. Another possible complication of this technique 
is that diffuse of KCL in the target amniotic sac, may lead to diffuse to adjacent sac, thus 
makes harm to the intrauterine embryo.  
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7.3 Rare ectopic pregnancies  
7.3.1 Cervical pregnancies 
A heterotopic cervical pregnancy treated with TVS-guided aspiration at day 34 after her 
embryo transfer, developed of uterine varices at the cervical site, bilateral hypogastric artery 
occlusion was used while a fundal classic cesarean section at 37 weeks gave birth to an 
infant (Shah et al., 2008). Uterine varices were diagnosed at 28 weeks gestation, as 
prominent vessels associated with the empty sac located anteriorly and posteriorly 
occupying a significant portion of the myometrium of the lower uterine segment and 
cervical stroma. Venous waveforms were observed on Doppler studies. Fundal C section 
was planned to avoid entry into the gestational tissue and vasculature that occupied the 
lower uterine segment. After delivery, the patient went for pelvic angiography and possible 
embolization to diminish the risk of bleeding.  
Prorocic et al. described the treatment of a heterotopic cervical pregnancy with TVS-guided 
aspiration and instillation of hypertonic solution of sodium chloride and ligation of 
descending cervical branches of the uterine arteries (Prorocic et al., 2006). The latter took 
place before TVS guided aspiration. By vagina retraction, two DEXON sutures were placed 
bilaterally on the cervix, high below the fornix vaginae thus reducing hemorrhage, 
significantly. Twin pregnancy in the uterine cavity continue to grow till article publication 
(at 12th week of pregnancy).  
A cervical twin ectopic pregnancy has been described by Aboulfoutouh et al. (Aboulfoutouh 
et al., 2011). Treatment consistent from transvaginal ultrasound-guided aspiration plus 
systemic single injection of methotrexate.  
A 37-year-old woman after IVF developed severe ovarian hyperstimulation syndrome. 
Transvaginal ultrasound revealed two gestational sacs with one viable fetus located below 
the internal cervical os at 7 weeks’ gestation while Doppler imaging demonstrated a cervical 
mass containing numerous tortuous and dilated blood vessels and vascular communication 
beds in the implantation site and established abundant peritrophoblastic arterial flows. 2 
days later developed vaginal bleeding and Intracervical Foley catheter tamponade was 
performed. Persistently active gestatinal tissue and bleeding leads to hysteroscopic 
endocervical resection (12-degree resectoscope with an outer diameter of 8 mm) in 
combination with temporary balloon occlusion of bilateral common iliac arteries (CIA). 
After complete removal of gestational tissue, electrocoagulation was done using the 
rollerball for homeostasis. After that, a 24-Fr Foley balloon catheter was placed at the 
cervical canal to achieve homeostasis while methotrexate 50 mg im was injected on the 
following day, and the 24-Fr Foley balloon catheter was removed 3 days after surgery (Yang 
et al., 2010). Same method of treatment was used by Peleg et al. (Peleg et al., 1994).  
A 45-year-old woman, diagnosed by ultrasound with a triplet gestation 7 weeks following 
IVF. Transvaginal ultrasound showed a triplet heterotopic pregnancy consisting of two 
gestational sacs in the cervix and one in the uterine cavity. Termination of pregnancy was 
decided for future fertility preservation with catheterization and methotrexate treatment. 
The right femoral artery was catheterized with catheter and the uterine arteries were 
cannulated. 42 mg of methotrexate were injected into the right and left uterine arteries (total 
dose of 84 mg (50 mg/m2)). Pledgets of Gelfoam were then used to embolize the arteries. 
Follow-up ultrasound scan (after 48 hours) revealed an absence of cardiac activity in both 
embryos. A gradual shrinkage of the cervical and intrauterine sacs was seen later (Nitke et 
al., 2007).  
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A 37-year-old woman undergone ICSI, due to severe oligoasthenoteratospermia, diagnosed 
with transvaginal ultrasound two gestational sacs with embryonic heartbeats, one in the 
cervical region and the second intrauterine. Hysteroscopic removal of the cervical 
gestational sac was chosen, to preserve the intrauterine pregnancy. The gestational sac was 
observed on the left side of the endocervical canal 2 cm away from the internal cervical 
ostium The tip of the resectoscope did not go beyond the internal cervical os during the 
operation, and the uterine cavity was not touched. By roller ball electrocatery was used for 
the conception products. Cautery settings were 100 W for cutting, and the coagulation 
current blend was 1. The entire procedure was performed under continuous ultrasound 
guidance with an abdominal probe (Jozwiak et al., 2003).  
A viable intrauterine and cervical pregnancy was diagnosed in a 34-year-old woman in her 
4 IVF attempts. With transabdominal scanning, needle was inserted transcervically and 
maneuvered into the embryo fetal heart that ceased. After that KCl injected. Then 3 cm3 of 
saline were injected for better visualization of the cervical fetus, and to confirm absence of 
heart beat. The intrauterine pregnancy delivered art 36,5 wks (Carreno et al., 2000).  
A heterotopic cervical pregnancy diagnosed 25 days after ET because the patient reported 
some mild vaginal bleeding. Transvaginal ultrasound and Doppler vascular blood flow 
confirmed the suspected heterotopic cervical pregnancy that was treated with transvaginal 
ultrasound-guided aspiration and KCL injection in the heterotopic pregnancy cavity. Sixteen 
days after the procedure, and under epidural anesthesia, hemostatic synthetic absorbable 
sutures were placed high on the cervix at 1, 3, 9, and 10 o’clock, ultimately circumferentially 
tying the cervix. Cervical-stay sutures dissolved by the 18th–20th weeks of gestation while no 
cervical incompetence was observed. At 38 weeks of gestation, via cesarean section an infant 
was delivered. For safety precautions, during the procedure, interventional radiologists 
were on standby to perform uterine artery embolization if necessary (Chen et al., 2001).  
7.3.2 Ectopic pregnancies developed in a scar  
7.3.2.1 Previous myomectomy scar 
Although pre-IVF myomectomy is not a necessity to achieve an ongoing pregnancy 
(Vimercati et al., 2007), other authors prefer to perform it, especially when repeated 
implantation failures takes place (Margalioth et al., 2006) or uterine cavity involvement 
exists (Klatsky et al., 2007). In a retrospective study for laparoscopic myomectomy 
outcomes, Paul et al, mentioned a 5.2% EP rate (Paul et al., 2006). In the same year, 
Seracchioli et al., reported an EP rate of 2.6% (Seracchioli et al, 2006). From the other side 
Campo et al, found no ectopic in their series after laparoscopic myomectomy (Campo et al., 
2003). None of the ectopic pregnancies developed in the scar of the previous myomectomy.  
7.3.2.2 Previous Caesarean scar (CSP) 
Cesarean scar pregnancy carry the high risk of uncontrollable bleeding requiring 
hysterectomy, so management has to include this risk in its treatment options.  
Wang et al, described a heterotopic pregnancy combined with intrauterine pregnancy after 
IVF (Wang et al., 2007). Embryo reduction was performed with transvaginal ultrasound 
guided KCL injection (0.2ml) at 10 wks gestation. A mass 3x3 cm remained till 32 wks 
gestation A male was delivered at 35 weeks delivered by CS. Remaining gestational tissue 
leads to massive blood loss after CS, blood transfusion and bilateral internal iliac arteries 
ligation.  
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Another author (Wang et al., 2010) found a Cesarean Scar pregnancy (within the isthmic 
area of the lower anterior wall of the uterus) and an intrauterine pregnancy after IVF. At this 
time, management was performed by hysteroscopy evacuation at 7 wks gestation and 
coagulation of the implantation vessel site. Cervix was dilated to 11 mm, not beyond the 
endocervical canal and gestational sac was pulled out, under sonographic guidance. Suction 
curettage was used to clear the residual gestational tissue and a hysteroscopic rolling ball 
was used to stop the bleeding point. A healthy infant delivered by Cs at 39 wks gestation.  
From the other side two different cases was presented by Chueh et al., 2008. Both cases were 
a twin cesarean scar pregnancy. Ectopic pregnancies were treated either by laparotomy 
excision of the scar twin pregnancy (first case) and hysterosocpic resection (second case) 
with resectoscopic coagulation of placenta bed vessels. In both cases, no fluid was seen in 
the cul-de-sac.  
More pregnancies could be observed in cesarean scar. Litwicka et al, described a triplet 
heterotopic cesarean scar pregnancy after IVF, a twin pregnancy in the anterior isthmic wall 
close to the CS scar (separated from the bladder wall by a thin myometrial layer) and one 
intrauterine gestational sac (Litwicka et al., 2010). Caesarian scar gestation sacs have been 
diagnosed,one week later than the intrauterine sac. Transvaginal ultrasound-guided 
potassium chloride (2 ml) and methotrexate (15 mg) was injected in the ectopic gestational 
sacs while the intrauterine pregnancy continue to ongoing pregnancy.  
In another case, described by Hsieh et al, a heterotopic triplet pregnancy was evident after 
IVF treatment, two intrauterine pregnancies and one cesarean scar pregnancy (Hsieh et al., 
2004). Color Doppler sonography revealed proliferated peritrophoblastic vessels around the 
Caesarean scar pregnancy and the intrauterine twin pregnancy. CSP was treated with 
embryo aspiration under vaginal ultrasonography with preservation of intrauterine twin 
pregnancy. Due to preterm labour, two infants delivered at 32 wks gestation.  
Rare CSP may exist at different forms after IVF treatments and previous CS. The 
management of these pregnancies may be performed with laparotomy or hysteroscopic 
resection of CS ectopic tissue after KCL lethal injection to embryo. Also MTX may be used 
for the second case. Complications of the second treatment include spontaneous abortion 
and congenital abnormality of MTX or diffuse of KCL in the target amniotic sac that may 
lead to diffuse to adjacent sac.  
7.3.3 Live twin pregnancy in the same fallopian tube 
A left fallopian tube twin pregnancy was presented by Atabekoğlu et al., an isthmic 
pregnancy and another ampullary sac in the same tube (Atabekoğlu et al., 2009). Both 
treated with a left laparoscopic salpingectomy.  
7.3.4 Cul-de-sac pregnancy 
A case of a cul-de-sac ectopic pregnancy after IVF, was described by Shih et al. (Shih et al., 
2007). After 4 weeks from ET it was found an ectopic gestational sac with fetal heart beat in 
the left adnexa. It was revealed, by laparoscopy, an ectopic mass in the congenital blind 
pouch that was connected to the posterior cul-de-sac. Laparotomy was used for removal of 
conceptus and homeostasis.  
7.3.5 Hepatic pregnancy 
Although a lot of case reports exist for a hepatic pregnancy in the literature (Chin et al., 
2010; Moores et al., 2010), none of them is reported after IVF, so they mentioned as primary 
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hepatic pregnancy. Chlamydia infections may involved also in this type of ectopic because 
adhesions between and liver the diaphragm (Fitz-Hugh-Curtis Syndrome) were 
demonstrated in 34% of those with EP (Picaud et al., 1991). Treatment of this type of 
pregnancy included direct methotrexate injection (Nichols et al., 1995), laparoscopic 
suctioning and homeostasis (Chin et al., 2010) or laparotomy. In case an advanced week’s 
live pregnancy is diagnosed, then laparotomy with intact placenta may be performed 
(Shukla et al., 1995).  
7.3.6 Intrauterine and twin bilateral tubal pregnancy 
Pan et al, report a case of bilateral tubal pregnancy and intrauterine pregnancy (Pan et al., 
2002). After right tubal embryo transfer (due to cervical stenosis) of four embryos, in 5th 
week, a laparotomy showed a ruptured right tubal pregnancy, hemoperitoneum and a 
dilated left tube. Bilateral salpingectomy was performed with preservation of intrauterine 
pregnancy and deliver of a male at term.  
7.3.7 Intrauterine and interstitial heterotopic pregnancy after bilateral salpingectomy 
Patient had two previous unsuccessful IVF cycles and removed both tubes for bilateral 
hydrosalpinges. After that she preformed a third IVF cycle. She developed an intrauterine 
pregnancy and an interstitial pregnancy that ruptured at the left salpingectomy site by its 
lateral position to the insertion of the ipsilateral round ligment. After laparotomy and left 
cornual resection, intrauterine pregnancy survived two more weeks and miscarried. 
Trisomy 21 was revealed, in aborted fetus (Dumesic et al., 2001).  
7.3.8 Cornual pregnancy 
Two studies exist that describe cornual pregnancy after IVF. First case was a heterotopic triplet 
pregnancy after in utero transfer of three embryos (Divry et al., 2006). Cornual pregnancy was 
treated with resection by laparotomy. A special technique was presented in this patient. A 
Vicryl string with a tight knot was inserted at the base of the implantation site of the corneal 
pregnancy and the base of the uterine wall above this string was sectioned. Cornual scar was 
closed with same stitches in X form while a base knot left in place. Intrauterine twin pregnancy 
continue uneventfully till 31 wks gestation, where the patient delivered two girls with 
Csection. The site of the corneal pregnancy was well vascularrized and not ruptured.  
The second case was a recurrent spontaneous cornual pregnancy 2 years after a heterotopic 
cornual pregnancy occurred after IVF cycle (van der Weiden et al., 2005). Previous cornual 
heterotopic pregnancy was treated with injection of 0.5 ml of 15% potassium chloride into 
the fetal heart while normal pregnancy was delivered at 39 weeks of gestation by elective 
caesarean section. Spontaneous cornual pregnancy was treated by injection of 40 mg 
methotrexate in the gestational sac and systemic methotrexate (1.0 mg/kg orally alternated 
with 15 mg folinic acid).  
7.3.9 Interstitial pregnancy 
Berkes et al., reported a unilateral triplet ectopic pregnancy, on a woman with a history of 
right salpingectomy (Berkes et al., 2008). After IVF, in the left fallopian tube, a triplet 
pregnancy was found (two pregnancies at interstitial and one at ampullary location). Color 
flow Doppler sonography revealed intensive perithrophoblastic blood flow around the two 
gestational sacs with live embryos while TVS showed threegestational sacs,in the left 
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interstitial area,in the isthmic part of the fallopian tube and in the ampullar part next to the left 
ovary. After multiple dose of methotrexate, hCG levels were lowered but pregnancies were 
ruptured, so a laparotomy was performed with the removal of the left tube and cornual part of 
the uterus. Another case of previous bilateral salpingectomy and IVF was reported by Chang 
et al. (Chang et al., 2003). An intrauterine monozygotic twin and an interstitial monozygotic 
twin pregnancy were reported. By laparotomy, interstitial pregnancy was removed and 
intrauterine pregnancy allowed delivering at 38 wks gestation. Another intrauterine 
monochorionic diamniotic twin pregnancy and an interstitial pregnancy were reported by 
Nikolaou et al. (Nikolaou et al., 2002). Also after bilateral salpingectomy and IVF, interstitial 
heterotopic pregnancy was developed that ruptured (Dumesic et al., 2001). A recurrent 
interstitial pregnancy in uterine horn was seen after IVF (Muzikova et al., 2003).  
Laparoscopic loop ligature was used by Qin et al, for heterotopic interstitial pregnancy (Qin 
et al., 2008). Perez et al., reported medical therapy in two cases of interstitial pregnancy, one 
with transvaginal ultrasound guided injection of methotrexate and second with potassium 
chloride into the ectopic sac of the heterotopic twins (Perez et al., 1993).  
Overall, interstitial pregnancies are always possible after tubal occlusion.  
7.3.10 Rare cases of mild ovarian hyperstimulation and ectopic pregnancy  
Korkontzelos et al., reported the co-existence of ovarian hyperstimulation with  ascetic 
fluid accumulation, enlarged ovaries after IVF and a right tubal ectopic pregnancy 
(Korkontzelos et al., 2006). Right salpingectomy was performed. Same case was presented 
by Fujii et al., which ended in a bilateral salpingectomy and continuation of intrauterine 
pregnancy till 32 wks of gestation (Fujii et al., 1996).  
7.3.11 Consecutive recurrent ectopic pregnancies  
Three consecutive recurrent pregnancies have been reported in the same patient with pelvic 
inflammatory disease, two in the right fallopian tube and one in the left. Laparotomy was 
performed in all three cases, to preserve the tubes while removing conceptus (Adelusi et al., 
2003). Another case of two consecutive ectopic pregnancies after IVF, was presented by 
Abu-Musa et al. (Abu-Musa et al., 2002). Three consecutive cases of ectopic pregnancy on 
the same patient was presented by Oki et al., 1998. The first involved simultaneous 
intrauterine and left tubal pregnancy, the second was a right tubal pregnancy, and the third 
was a right interstitial pregnancy. Another case of two ectopic pregnancies in consecutive 
menstrual cycles was presented by Irvine et al. (Irvine et al., 1999). Left distal ectopic 
pregnancy was seen and treated with left partial salpingectomy while in the next cycle a 
right distal ectopic pregnancy was observed which treated with right partial salpingectomy. 
Except the second case, the other two patients conceived by coitus, so cases are presented in 
this review because they are rare. Another report of recurrent cornual ectopic pregnancy has 
been presented (MacRae et al., 2009) but presentation is beyond the scope of this 
manuscript.  
8. Section 5 
8.1 Cost effectiveness 
8.1.1 Chlamydia trachomatis -ectopic pregnancy-cost effectiveness 
Eight studies described cost-effectiveness of Chlamydia screening for pregnancy 
complications, including ectopic pregnancy. For most of them, proactive screening of 
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Chlamydia is not cost-effective when tested in general population (Buhaug et al., 1989; 
Roberts et al., 2007; van Valkengoed et al., 2001) and that only when women aged 18 to 24 
years old tested or prevalence of Chlamydia is over 3% (Postma et al., 2000) or 2% 
(Trachtenberg et al., 1988), cost-effectiveness exist for prevention of ectopic pregnancy. Hu 
et al, pointed out that annual screening for Chlamydia is indicated for women 15 to 29 years 
of age and selective targeting with semiannual screening of those women with a history of 
infection (Hu et al., 2004). Partner treatment should be provided (Postma et al., 1999) to 
avoid re-infection. Another author (Schiøtz et al., 1991) found that routine post-treatment 
control of non- systematic genital Chlamydia infection is not cost-beneficial.  
8.1.2 Ultrasound for diagnosis of ectopic pregnancy-cost-effectiveness 
In an emergency department, to rule out the possibility of ectopic pregnancy, the most cost 
effective strategy is to screen all patients with first trimester bleeding and lower abdominal 
cramping with ultrasound (Durston et al., 1999), even if the scan is performed by an 
emergency doctor. Obviously this technique is not cost-effective in symptoms free women 
(Mol et al., 2002).  
8.1.3 Laparoscopic treatment for Ectopic pregnancy-cost effectiveness 
When laparoscopy is compared with methotrexate for its cost savings, methotrexate saves 
about 1000, Canadian dollars (Yao et al, 1996). In a decision and cost-effectiveness analysis, 
Seror et al., found that first line treatment with methotrexate is more cost-effective than 
conservative laparoscopy and radical laparoscopy in sub-acute ectopic pregnancy (Seror et 
al., 2006). Conservative laparoscopy was more cost-effective than radical laparoscopy in this 
group of patients, in terms of fertility preservation. Methotrexate treatment effectiveness 
was increased when diagnostic ultrasound accuracy is increased. If patient after an IVF 
ectopic pregnancy treated with methotrexate, then, in the next cycle, similar ovarian 
stimulation characteristics could be obtained (Orvieto et al., 2007).  
9. Conclusion 
In this systematic review we presented the most important studies dealing with ectopic 
pregnancy after in vitro fertilization. Also, important biological factors that play a role for EP 
has been presented. Case reports of ectopic pregnancies their position in the uterus, and the 
steps undertaken to preserve intrauterine pregnancy has been described. Complications of 
these treatments, where available, have been mentioned. Practices during in vitro 
fertilization treatment and their controversial role for this pregnancy complication have 
been described. Overall, cost-effectiveness studies in the ectopic pregnancy prediction and 
management has been described. New research directions have been pointed out.  
Although ectopic pregnancies and more specific heterotopic pregnancies are rare, these 
increase due to infertility treatment. Active and aggressive management of hydrosalpinx has 
been proposed for heterotopic pregnancy minimization after IVF.  
All combinations of heterotopic pregnancies have been described. The major complication was 
bleeding and rupture of pregnancy. Care was taken for intrauterine pregnancy continuation 
but many cases miscarried after some time. Laparoscopy and hysteroscopy were methods of 
choice but laparotomy was chosen when threat of major bleeding was expected. Another 
method of treatment was vaginal aspiration of embryo sac after a lethal injection with a 
pharmacological agent. Most cases have not recognized till rupture of ectopic pregnancy.  
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The majority of studies were case report and retrospective studies. Even if more studies exist 
in a specific issue (e. g. ectopic pregnancy rates in fresh and frozen IVF cycles) these are not, 
homogenously designed, and no data synthesis could be made. Also in the management of 
heterotopic pregnancies, a single methodology was not used, so no best practices outcome 
could be formed. Screening for ectopic pregnancy show better cost-effectiveness only when 
we expect increased prevalence of this entity (Roberts et al., 2007; van Valkengoed et al., 
2001) or women age from 18 to 24 years old (Buhaug et al., 1990). Also general population 
screening program for C. Trachomatis, show that costs exceeds the benefits to avoid ectopic 
pregnancy. The method of choice for treatment is laparoscopy, because show similar cost-
effectiveness but less invasiveness (Gray et al., 1995) than laparotomy. Combination 
therapies, like uterine artery embolization and laparoscopy has been used for complications 
like hemorrhage. Although these therapies are expensive, the rare cases do not allow a cost-
effectiveness analysis to be performed.  
Many heterotopic pregnancies were identified after EP rupture, thus leading to a 
laparoscopy or laparotomy and possible complications while an early identification may 
lead to MTX therapy, that is by far a more cost-effective treatment strategy. From the other 
side, close ultrasound monitoring has revealed heterotopic pregnancies developed in 
previous Caesarean scar pregnancy, cervical pregnancies etc. So for IVF patients, more 
intense ultrasound and b-hCG monitoring is required. It is not known yet whether this 
applies to all patients that had an ET or only in the subgroup of patients with risk factors for 
EP undergoing ET.  
Many ectopic pregnancies remained unidentified with viable pregnancies till second 
trimester. It is important, for these cases, to improve our detection capabilities with new 
approaches. Heterotopic pregnancy may present with different combinations and uterine 
locations, at various gestational ages, even when the intrauterine pregnancy aborts. 
Eventually the presence of an intrauterine gestation sac in a patient without symptoms 
should not exclude the diagnosis of a concomitant extrauterine pregnancy until the pelvis is 
carefully visualized (Rizk et al., 1991). Currently, no biomarker could early identify an 
ectopic pregnancy, especially a heterotopic one. A promising non invasive marker could be 
developed from the use of cervical trophoblastic cells and special markers on them.  
Regarding the IVF procedure, infertility medication should be used cautiously from non-
specialists and ovulation induction has to be preformed always under close monitoring. In 
case of altered tubal motility, close monitoring of pregnancy as evolves, should be 
performed.  
Chlamydia infections and tubal factor infertility still remain the major factor for EP after 
IVF. Active management for hydrosalpinx seems to lower EP rates, but still no minimal 
invasive test exists. No other IVF technique could be accounted for increased ectopic 
pregnancy rates except the transfer of multiple embryos, especially more than two. Where 
indications exist for increased EPs after specific techniques (e. g. assisted hatching), more 
clinical trials should be performed, controlled also for EP factors. Tubal transfer techniques 
(ZIFT) have been abandoned through years, so they could not account for EP in the modern 
era. Tubal reanastomosis also is not practiced in all IVF clinics, and only where it is 
practiced it has to be considered as a factor of tubal pregnancy.  
Another issue that needs to be checked is the association of ectopic pregnancy and the 
abnormal embryogenesis. This is important for male factor infertility and increased age. It is 
not clear yet whether more intense pregnancy monitoring should apply in these patients.  
www.intechopen.com
 Ectopic Pregnancy – Modern Diagnosis and Management 
 
68
As a general policy, individual IVF practices should evaluate their EP rate in an attempt to 
identify factors that may increase or decrease the rate compared to national statistics 
(Keegan et al., 2007).  
It is not clear yet, whether a single biological pathway should account for ectopic pregnancy. 
Although TB implantation mechanism is different from normal uterine mechanism, tubal 
pregnancies should be used to study embryo implantation. Invasive pathway, as described 
in ectopic pregnancy seems to be important. Another pathway that may be involved is the 
NO pathway that is altered through the Chlamydia infection altered immune response.  
Researchers performing RCTs in ectopic pregnancies need to consider certain issues in their 
design. Patients differ in age and the infertility factor. A trial has to control for the number 
of embryos transferred, the quality of them and patients demography because a common 
underlying risk factor might exist. A clear measure of complications has to be developed, 
especially for cost effectiveness studies. Because ectopic pregnancies after IVF always need 
intervention, no placebo trials could be performed. Length of follow up and follow up plan 
need to be decided before hand, so pregnant women need to have standardized care. Level 
of training for the providers of IVF services seems to be important.  
Ruptured ectopic pregnancies may present with severe complications, due to hemorrhage. 
Currently, no single treatment plan is chosen and different groups perform different 
approaches. Although these treatments are life saving, they are not cost effective. It is 
important for hospitals with large IVF groups to undertake such studies, so knowledge to be 
transferred to smaller groups. In case of heterotopic pregnancy, it is important to know how 
to protect the intrauterine embryo (as valuable pregnancy), so research should direct to this 
also.  
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